Carrieri M P, Chesney M A, Spire B, Loundou A, Sobel A, Lepeu G, Moatti J P
INSERM, Research Unit 379 Marseille, France.
Int J Behav Med. 2003;10(1):1-14. doi: 10.1207/s15327558ijbm1001_01.
The study, carried out in the French MANIF 2000 cohort of HIV positive patients contaminated through injecting drug use, assessed the impact of patients' sociodemographic and psychological characteristics, behaviors toward drug abuse, and antiretroviral treatment characteristics on the maintenance of adherence to HAART (highly active antiretroviral therapies). A total of 96 patients (30 men and 66 women), who were initially adherent at their first visit after HAART prescription, were considered for analysis. Among these 96 patients, 22 (22.9%) experienced adherence failure defined as a self-reported, non-adherence behavior at any visit before the 18th month of treatment. Logistic regression showed that lack of a stable relationship, active drug injection, and depression were independently associated with adherence failure. Patients' counseling for facilitating maintenance of adherence to HAART over time should focus on prevention of drug use, provision of social support and consider the potential impact of difficulties with treatment on psychological well-being.
这项研究在法国MANIF 2000队列中针对通过注射吸毒感染艾滋病毒的阳性患者开展,评估了患者的社会人口学和心理特征、药物滥用行为以及抗逆转录病毒治疗特征对维持高效抗逆转录病毒疗法(HAART)依从性的影响。共有96名患者(30名男性和66名女性)被纳入分析,这些患者在HAART处方后的首次就诊时最初是依从的。在这96名患者中,22名(22.9%)出现了依从性失败,定义为在治疗第18个月之前的任何一次就诊时自我报告的不依从行为。逻辑回归显示,缺乏稳定关系、活跃的药物注射和抑郁与依从性失败独立相关。为促进患者长期维持HAART依从性而进行的咨询应侧重于预防药物使用、提供社会支持,并考虑治疗困难对心理健康的潜在影响。